Olanzapine in Anorexia Cachexia Syndrome Among Advanced Cancer Patients
Condition:   Anorexia Interventions:   Drug: Olanzapine 5 MG;   Drug: Placebo Sponsor:   Cairo University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 17, 2022 Category: Research Source Type: clinical trials

Olanzapine Combined With Fosaprepitant, Ondansetron, and Dexamethasone for Preventing Nausea and Vomiting in Patients With Testicular Cancer
Conditions:   Olanzapine;   CINV;   Testicular Cancer by AJCC V6 and V7 Stage;   Cisplatin Interventions:   Drug: Olanzapine Tablets;   Drug: Placebo Sponsor:   Shi Yanxia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 17, 2022 Category: Research Source Type: clinical trials

Olanzapine in Anorexia Cachexia Syndrome Among Advanced Cancer Patients
Condition:   Anorexia Interventions:   Drug: Olanzapine 5 MG;   Drug: Placebo Sponsor:   Cairo University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 17, 2022 Category: Research Source Type: clinical trials

Olanzapine Combined With Fosaprepitant, Ondansetron, and Dexamethasone for Preventing Nausea and Vomiting in Patients With Testicular Cancer
Conditions:   Olanzapine;   CINV;   Testicular Cancer by AJCC V6 and V7 Stage;   Cisplatin Interventions:   Drug: Olanzapine Tablets;   Drug: Placebo Sponsor:   Shi Yanxia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 17, 2022 Category: Research Source Type: clinical trials

Olanzapine in Anorexia Cachexia Syndrome Among Advanced Cancer Patients
Condition:   Anorexia Interventions:   Drug: Olanzapine 5 MG;   Drug: Placebo Sponsor:   Cairo University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 17, 2022 Category: Research Source Type: clinical trials

Fosaprepitant , Tropisetron and Olanzapine for the Prevention of Nausea and Vomiting in Patients With Breast Cancer Receiving Anthracycline/Cyclophosphamide-containing Chemotherapy
Condition:   Chemotherapy-induced Nausea and Vomiting Interventions:   Drug: Fosaprepitant , Tropisetron and Olanzapine;   Drug: Fosaprepitant , Tropisetron, Dexamethasoneand Olanzapine Sponsor:   Henan Cancer Hospital Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 16, 2022 Category: Research Source Type: clinical trials